These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37879215)

  • 1. Bruceine A: Suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer.
    Li X; Liu C; Zhang X; Sun C; Ling J; Liu Y; Zuo Y; Cao Y; Zhang C; Jiang T; Wang M; Liu J; Lu J
    Biomed Pharmacother; 2023 Dec; 168():115784. PubMed ID: 37879215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling.
    Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
    Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis.
    Zhang Y; Wei S; Zhang Q; Zhang Y; Sun C
    Phytomedicine; 2024 Jul; 130():155746. PubMed ID: 38763012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
    Lee J; Lim B; Pearson T; Choi K; Fuson JA; Bartholomeusz C; Paradiso LJ; Myers T; Tripathy D; Ueno NT
    Breast Cancer Res Treat; 2019 Jun; 175(2):339-351. PubMed ID: 30826934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aesculetin Inhibits Proliferation and Induces Mitochondrial Apoptosis in Bladder Cancer Cells by Suppressing the MEK/ERK Signaling Pathway.
    Han L; Li P; Fu X; Huang Z; Yin W
    Anticancer Agents Med Chem; 2023; 23(4):478-487. PubMed ID: 35708085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
    Van Swearingen AED; Sambade MJ; Siegel MB; Sud S; McNeill RS; Bevill SM; Chen X; Bash RE; Mounsey L; Golitz BT; Santos C; Deal A; Parker JS; Rashid N; Miller CR; Johnson GL; Anders CK
    Neuro Oncol; 2017 Oct; 19(11):1481-1493. PubMed ID: 28486691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR and MEK Blockade in Triple Negative Breast Cancer Cells.
    Maiello MR; D'Alessio A; Bevilacqua S; Gallo M; Normanno N; De Luca A
    J Cell Biochem; 2015 Dec; 116(12):2778-85. PubMed ID: 25959272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bruceine A inhibited breast cancer proliferation and metastasis by inducing autophagy via targeting PI3K-AKT signaling pathway.
    Gao Z; Zhang Y; Shen W; Liu X; Wei Y; Li L; Cui H
    Chem Biol Drug Des; 2024 Jan; 103(1):e14398. PubMed ID: 38010171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroform Fraction of Methanolic Extract of Seeds of Annona muricata Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer.
    Kariyil BJ; Ayyappan UPT; Gopalakrishnan A; George AJ
    Anticancer Agents Med Chem; 2021; 21(10):1250-1265. PubMed ID: 32951586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
    Yue SJ; Zhang PX; Zhu Y; Li NG; Chen YY; Li JJ; Zhang S; Jin RY; Yan H; Shi XQ; Tang YP; Duan JA
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling.
    Cheng W; Liu D; Guo M; Li H; Wang Q
    Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARγ/AMPK signaling pathway.
    Yang X; Yang R; Zhang Y; Shi Y; Ma M; Li F; Xie Y; Han X; Liu S
    Biomed Pharmacother; 2023 Sep; 165():115164. PubMed ID: 37478577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
    Hong Y; Fan D
    Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.
    Qin H; Liu X; Li F; Miao L; Li T; Xu B; An X; Muth A; Thompson PR; Coonrod SA; Zhang X
    Cancer Lett; 2017 Nov; 409():30-41. PubMed ID: 28844713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFIC1 inhibits the migration and invasion of MDA-MB-231 cells through S100A2-mediated inactivation of MEK/ERK pathway.
    Zhang J; Wang Z; Liang Z; Jin C; Shi Y; Fan M; Hu X; Wan Y
    Arch Biochem Biophys; 2023 Jan; 734():109497. PubMed ID: 36574914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese medicine formula 'Baipuhuang Keli' inhibits triple-negative breast cancer by hindering DNA damage repair via MAPK/ERK pathway.
    Mi S; Liu X; Zhang L; Wang Y; Sun L; Yuan S; Cui M; Liu Y
    J Ethnopharmacol; 2023 Mar; 304():116077. PubMed ID: 36572327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine.
    Ghosh S; Adhikary A; Chakraborty S; Bhattacharjee P; Mazumder M; Putatunda S; Gorain M; Chakraborty A; Kundu GC; Das T; Sen PC
    J Biol Chem; 2015 Feb; 290(7):3936-49. PubMed ID: 25527500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced expression of miR-1250-5p exerts tumor suppressive role in triple-negative breast cancer cells.
    Shuaib M; Kumar S
    J Cell Biochem; 2023 Feb; 124(2):282-293. PubMed ID: 36548440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
    Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
    Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.